In honor of my daughter’s first birthday later this month, I’m going to take the month off from reporting on Republican action on drug prices to share why prescription drug price reform matters to my family.
In his address to Congress last week, President Biden promised to give Medicare the power to negotiate lower prices for prescription drugs. Yet despite the encouraging rhetoric, he notably left prescription drug prices out of his latest legislative proposals in the American Families Plan.
In looking back at drug price politics in March, in her April 2nd update covering the Democrats on this issue, my fellow board member Colleen Kenny LaRocque reminds us that Democrats may want bipartisanship to lower drug prices, but they don’t need it. Bipartisanship on drug prices is not dead, as Prescription Justice member Lindsay Brown informs us in “Bipartisanship is the Key to GOP's Future in Drug Prices.” Finally, I’m excited that Isaiah Cochran, MD, made his debut blog post as a Prescription Justice board member this past week.